Related Experiment Videos
Intratumoral heterogeneity in gastric cancer: a new challenge to face
M Alsina1, I Gullo2,3,4,5, F Carneiro2,3,4,5
1Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Early-onset gastrointestinal cancer patterns in Navarre: incidence, tumour features and patient survival outcomes.
ESMO real world data and digital oncology·2026
Dose optimization of immune checkpoint inhibitors for gastrointestinal malignancies.
ESMO gastrointestinal oncology·2026
Gastric cancer hospital-based registry: real-world gastric cancer data from Latin America and Europe.
ESMO gastrointestinal oncology·2026
Higher rate of pathologic complete response in patients with early-onset locally advanced rectal cancer.
ESMO gastrointestinal oncology·2026
Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade ovarian cancer: Results from the first-in-human phase 1 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase Ib study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Kidney Transplantation From a Heterozygous CLDN19 Carrier in a Child With FHHNC: A 2-Year Follow-Up.
Pediatric transplantation·2026
Effects of Telomere Related Senescence-Genes in Cervical Cancer.
Reproductive sciences (Thousand Oaks, Calif.)·2026
Microbial cues and T cell immunity: deciphering their interactions in chronic liver disease.
Experimental & molecular medicine·2026
Learning cancer genetics from domestic cats.
Translational oncology·2026
Barriers and Strategies for Inclusive Clinical Trials: Focus Group Insights on Inclusivity, Diversity, Equity, and Accessibility.
Journal of clinical epidemiology·2026